Healthcare
Monday, November 28, 2016
BRIEF-Mylan signs sub-license agreement with the Medicines Patent Pool to produce and market DAKLINZA tablets to 112 countries
* Mylan signs sub-license agreement with the Medicines
Patent Pool to increase access to Hepatitis C treatment in
developing countries
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment